Veronica Diaz

Recommended Articles

• Nursing with Compassion: Easing the Final Journey

  There are those who might not know about the effects that compassionate nursing can have on someone, but at times, being compassionate is one of the greatest ways to care for someone. For some patients, at their last moments, they need someone who knows that they are there during their time of need....

• Gene Editing Has the Potential to Change Cystic Fibrosis

  Spiked Columnist, Tim Black, discusses advances in genetic editing in his article, Gene Editing: An Expression of Our Humanity.Tim Black questions how people should all consider the recent negative responses to some of the latest gene-editing successes. The majority of these gene-editing techniques...

• What are the Different Stages of Alzheimer's Disease?

  The symptoms of Alzheimer’s disease are seen years after the start of the disease, until the person remains ignorant about the presence of the condition. Symptoms begin to appear as the damage to brain cells increases with progress of the disease. The disease often passes through three stages –...

• Why Children Should Avoid Energy Drinks

  The American Academy of Pediatrics clearly mentions that children should not drink high-octane energy drinks and should avoid having sports drinks. Energy drinks are unhealthy because of the high content of caffeine and other stimulants present in the drink, according to a report published in,...

• Are there Medications to Treat Celiac Disease?

  The small intestine is a part of the digestive tract located after the stomach and before the large intestine. The inner surface of the small intestine which comes in contact with semi-digested food from the stomach has some small finger-like projections called villi that not only help to move food...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...